⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for myasthenia gravis, juvenile form

Every month we try and update this database with for myasthenia gravis, juvenile form cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)NCT03759366
Myasthenia Grav...
Myasthenia Grav...
Myasthenia Grav...
Eculizumab
6 Years - 17 YearsAlexion Pharmaceuticals, Inc.
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)NCT03759366
Myasthenia Grav...
Myasthenia Grav...
Myasthenia Grav...
Eculizumab
6 Years - 17 YearsAlexion Pharmaceuticals, Inc.
Predictors and Prognostic Factors of Myasthenia Gravis OutcomeNCT05214612
Myasthenia Grav...
Autoimmune Dise...
Neuromuscular J...
Thymoma
Thymus Hyperpla...
Nervous System ...
Myasthenia Grav...
Myasthenia Grav...
Myasthenia Grav...
Myasthenia Grav...
Myasthenia Grav...
Myasthenia Grav...
Drug treatment ...
16 Years - Assiut University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: